Rosidal® TCS is a two component compression bandaging system comprised of a soft, padded compression bandage and a cohesive, short stretch compression bandage. Safe-Loc™ system ensures correct compression at full stretch.
• Safe-Loc™ system ensures correct compression at full stretch
• Thin design to allow use of normal footwear
• First layer bandage provides compression and padding protection
• Second layer provides short stretch compression
Rosidal® TCS is indicated for use in the management of venous leg ulcers, edema and concomitant conditions.
Not recommended for use on patients with an ABI below 0.5.
Document absence of significant arterial disease.
No adverse effects or reactions have been reported.
No storage restrictions.
|Not made w/ natural rubber latex||●|
|Prescribed primarily for acute care|
|Prescribed primarily for post-acute care|
|Printed visual guide|
|Variety of colors|
|Zinc oxide impregnated|
|Educational Material Available|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Apply first Rosidal® TCS bandage (soft compression), foot to knee, using 50% overlap spiral technique. Apply second bandage (cohesive compression) at full stretch and 50% overlap using figure 8 technique.
May be left in place up to seven days depending on level of exudate.
Select primary dressings based on level of wound exudate.
L&R USA INC. (L&R) is part of a leading global medical device company, which has been delivering high quality healthcare products for over 160 years. L&R USA INC. is dedicated to providing health care professionals product solutions in the treatment of wounds, edema, venous disease, and lymphedema to improve patient care and outcomes.